Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoid Use in Progressive Inflammatory Brain Disease
2005-002728-33Phase 3Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dronabinol in multiple sclerosis (MS), sponsored by University Hospitals Plymouth. Primary endpoint: Physician-based EDSS progression. Started Dec 2005; status: completed.
02
Drugs
dronabinol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-002728-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002728-33.